Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update for axitinib in unresectable hepatocellular carcinoma has been completed.
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: Tremelimumab With Chemoembolization or Ablation for Liver Cancer [Phase 1, Phase 2]
Phase 1/2 trial exploring tremelimumab combined with chemoembolization or ablation for liver cancers has completed enrollment with results p…
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Trial to Evaluate Safety and Efficacy of Treatment of Physician Choice (TPC) Following First-Line Treatment of Lenvatinib in Subjects With Unresectable Hepatocellular Carcinoma (uHCC) [Phase 2]
A Phase 2 trial evaluating safety and efficacy of treatment selected by physician after first-line lenvatinib in unresectable hepatocellular…
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC [Phase 3]
A Phase 3 trial comparing sorafenib alone to sorafenib plus hepatic arterial infusion chemotherapy (HAIC) in advanced hepatocellular carcino…
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC [Phase 2]
Phase 2 clinical trial exploring anlotinib in combination with radiofrequency ablation (RFA) and transarterial chemoembolization (TACE) for …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC [Phase 3]
Phase III trial update for Trans-Arterial Chemo-Embolization (TACE) adjuvant therapy in hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent Hepatectomy [Phase 3]
A Phase 3 clinical trial evaluating the impact of neo-adjuvant transarterial chemoinfusion on survival in hepatocellular carcinoma patients …
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT [Phase 2]
Phase 2 trial evaluating toripalimab plus stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma [Phase 2, Phase 3]
Clinical trial update evaluating lenvatinib after liver transplantation in high-risk hepatocellular carcinoma patients (Phase 2/Phase 3).
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT [Phase 2]
Phase 2 trial update exploring PD-1 monoclonal antibody plus apatinib with SBRT for hepatocellular carcinoma with portal vein thrombosis.
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: Safety and Efficacy of Allogeneic NK Cells Therapy in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
A clinical trial update reports safety and efficacy data for allogeneic NK cell therapy in patients with advanced hepatocellular carcinoma (…
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma [Phase 1, Phase 2]
Clinical trial update evaluating safety and efficacy of TQB2450 with Anlotinib in advanced biliary adenocarcinoma and hepatocellular carcino…
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein [Phase 3]
A Phase 3 trial evaluating TheraSphere for inoperable liver cancer with portal vein blockage was terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus [Phase 1, Phase 2]
Clinical trial update on combination therapy of sorafenib and toripalimab for unresectable hepatocellular carcinoma with portal vein tumor t…
-
CLINICAL_TRIALS trial_result · 2019-09-26Clinical Trial Update: A Study of MG4101 (Allogeneic Natural Killer Cell) for Intermediate-stage of Hepatocellular Carcinoma [Phase 2]
Phase 2 trial update for MG4101, an allogeneic natural killer cell therapy, in intermediate-stage hepatocellular carcinoma (HCC) has complet…
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion [Phase 2]
Phase 2 clinical trial evaluating stereotactic ablative radiotherapy for hepatocellular carcinoma with major portal vein invasion has comple…
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma [Phase 2]
Phase 2 trial update on stereotactic body radiation therapy for hepatocellular carcinoma has been completed.
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm [Phase 2]
Phase 2 clinical trial evaluating stereotactic ablative radiotherapy for hepatocellular carcinoma lesions ≤ 5 cm.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC [Phase 3]
Phase 3 trial comparing SonoVue and Sonazoid using CEUS-LIRADS in hepatocellular carcinoma patients.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer [Phase 1, Phase 2]
A combined Irreversible Electroporation and NK immunotherapy trial for recurrent liver carcinoma has completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve [NA]
Clinical trial update on doxorubicin-eluting bead chemoembolization for hepatocellular carcinoma with marginal hepatic reserve; study termin…
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail [Phase 4]
A phase 4 randomized trial evaluating whether celecoxib prevents hand-foot syndrome caused by sorafenib in hepatocellular carcinoma patients…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy [Phase 3]
Phase 3 trial update comparing ADI-PEG 20 to placebo in advanced hepatocellular carcinoma after prior systemic therapy has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC [Phase 2]
A Phase 2 trial evaluating brivanib in Chinese patients with previously treated advanced hepatocellular carcinoma has been completed.
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Neoadjuvant Radiotherapy for HCC Involving Type I PVTT [Phase 2, Phase 3]
A Phase 2/3 trial update on neoadjuvant radiotherapy for hepatocellular carcinoma involving Type I portal vein tumor thrombus (PVTT).